CYLD and neoplasm: Initially identified as a tumor suppressor gene linked to cylindromatosis, a condition characterized by multiple benign skin tumors, recent research has reported that CYLD negatively impacts various signaling pathways, including NF-κB, Akt, and Wnt (98–100).